Why the study?
To summarize the current state of technology and clinical applications of CMR, improve diagnostic pathways, and promote its inclusion in clinical practice for cardiac disease.
This position paper provides appropriate use criteria for cardiovascular MRI in the evaluation of myocarditis, pericardial disease, cardiomyopathies, and valvular heart disease to improve clinical diagnostic pathways.
May inform CMR selection for diagnosis and risk stratification now; leaves open outcome validation of these consensus criteria.
Cardiovascular magnetic resonance (CMR) has emerged as an accurate diagnostic technique for the evaluation of patients with cardiac disease in the majority of clinical settings, thanks to an established additional diagnostic and prognostic value. This document has been developed by a joined group of experts of the Italian Society of Cardiology (SIC) and Italian Society of Radiology (SIRM) to provide a summary about the current state of technology and clinical applications of CMR, to improve the clinical diagnostic pathways and to promote its inclusion in clinical practice. The writing committee consisted of members and experts of both societies in order to develop a more integrated approach in the field of cardiac imaging. This section 2 will cover myocarditis, pericardial disease, cardiomyopathies and valvular heart disease.
No takes yet. Share an insight, caveat, or question.
Francone et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: